Neostigmine Methylsulfate Injection
Product Images NDC 51662-1557

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 51662-1557). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Inside Pouch (51662 1557 2 Box Labeling)

Carton Inside Pouch (51662 1557 2 Box Labeling)
Packaging label for Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) by HF Acquisition Co LLC, DBA HealthFirst. The label indicates intravenous injection use with a 10 mL multiple dose vial, includes a list of inactive ingredients, storage instructions, and a note to see the package insert for directions.*
FDA Label Image

Pouch Labeling (51662 1557 2 Pouch Labeling)

Pouch Labeling (51662 1557 2 Pouch Labeling)
Label for NEOSTIGMINE METHYLSULFATE Injection, USP, 1 mg/mL (10 mg per 10 mL) vial. It includes product identifiers such as NDC number 51662-1557-2, lot number 12345, and expiration date 2025-01-01. The label indicates it is for intravenous use in a 10 mL multiple dose vial and provides storage instructions and manufacturer information for HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Case Labeling (51662 1557 3 Case Labeling)

Case Labeling (51662 1557 3 Case Labeling)
Label for Neostigmine Methylsulfate Injection USP 10 mg per 10 mL (1 mg/mL) vial, box of 10, manufactured by HF Acquisition Co LLC, Mukilteo, WA. The label shows NDC 51662-1557-3, lot number 12345, and expiration date 2025-01-01. The product is for intravenous use with storage instructions.*
FDA Label Image

Serialized Labeling (51662 1557 3 Serialized Labeling)

Serialized Labeling (51662 1557 3 Serialized Labeling)
A white, rectangular drug packaging label for Neostigmine Methylsulfate injection distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label features a barcode, a matrix barcode, and several numeric codes, including a date and batch number. The label is marked "RX ONLY." No strength or dosage form details are visible on the label.*
FDA Label Image

Adverse 1 (Adverse 1)

Adverse 1 (Adverse 1)
A table listing adverse reactions associated with NEOSTIGMINE METHYLSULFATE injection. It categorizes side effects by system organ class, including cardiovascular disorders (bradycardia, hypotension), gastrointestinal disorders (dry mouth, nausea, vomiting), nervous system disorders (dizziness, headache), psychiatric disorders (insomnia), respiratory disorders (dyspnea, low oxygen saturation), and skin disorders (pruritus).*
FDA Label Image

Adverse 2 (Adverse 2)

Adverse 2 (Adverse 2)
A table listing adverse reactions categorized by system organ class for a drug. Categories include Allergic Disorders, Nervous System Disorders, Cardiovascular Disorders, Respiratory, Thoracic and Mediastinal Disorders, Skin and Sub-cutaneous Tissue Disorders, Gastrointestinal Disorders, Renal and Urinary Disorders, Musculoskeletal and Connective Tissue Disorders, and Miscellaneous. Each category details specific adverse reactions associated with that system.*
FDA Label Image

Description (Description)

Description (Description)
Chemical structure diagram of neostigmine methylsulfate, the active ingredient in this product, showing the arrangement of atoms including a benzene ring and methyl groups attached to nitrogen and oxygen atoms.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A data table listing NDC numbers, strengths, and vial sizes for Neostigmine Methylsulfate injection. It shows two strengths: 0.5 mg/mL and 1 mg/mL, each available in 10 mL multiple-dose vials supplied in packages of 10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.